Nexavar Significantly Improves Overall Survival By 47 Percent In Asia Pacific Liver C

New cases in Pous 2064, HIV = 175, AIDS = 26, Death = 2. HIV rate is very high in Housewives than sex workers in Nepal ! ! ! HIV status in Nepal till 2005: Total Adult=70000, Adult Prevalence (15-49)=0.55%, Number of Women (15-49) LWHA=15,310 (22%), HIV Prevalence rate in IDUs=32.7%, HIV prevalence rate in sex worker=3.8%, HIV prevalence rate in client of SW=2.1%. The latest U.N. report shows that 65 million people have been infected with HIV since it was first identified 25 years ago. Twenty five million people have died of AIDS.

Welcome to the xenoMED, an online Medical Community where Academically sound, Professionally conscious and Socially responsible Medical Students, Doctors & Health Professionals interact with each other globally.

Medicine is the only profession that incessantly tries to destroy its own existence. Howsoever you may be associated with basic and/or clinical medicine - student or professor, physician or surgeon, undergraduate or postgraduate - this is your place to share your knowledge, and learn more. Just get the message across!

You are currently viewing our communiy as a guest which gives you limited access to view most discussions and access our other features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content and access many other special features. Registration is fast, simple and absolutely free so please, Join Our Medical Cummunity Today!

If you have any problems with the registration process or your account login, please contact us.

		xenoMED > News Room > Health News > Medical News Today
Nexavar Significantly Improves Overall Survival By 47 Percent In Asia Pacific Liver C

LinkBack

Thread Tools

Display Modes

(#1 (permalink))

News is Offline

Senior Member

Posts: 627

Thanks: 0

Thanked 28 Times in 28 Posts

Join Date: Sep 2007

Nexavar Significantly Improves Overall Survival By 47 Percent In Asia Pacific Liver C - 17-05-2008, 02:02 AM

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) announced that Nexavar(R) (sorafenib) tablets significantly improved overall survival by 47.3 percent (HR=0.68; p-value=0.014) in patients in the Asia-Pacific region with advanced hepatocellular carcinoma (HCC), or primary liver cancer versus those receiving placebo.

More...

Remove advertisements

Sponsored links

« New Gene Methylation Test For Prostate Cancer Available | World's Largest Conference On Evolution To Be Hosted By University Of Minnesota »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts vB code is On Smilies are On [IMG] code is On HTML code is Off Trackbacks are On Pingbacks are On Refbacks are On

Similar Threads
Thread	Thread Starter	Forum	Replies	Last Post
546 QA Biochemistry Test	Oak	Step I	1	29-10-2007 11:23 PM
Nexavar Significantly Extends Overall Survival By 44 Percent In Liver Cancer Patients	Angel	Medical News Today	0	05-06-2007 07:02 PM
Liver Cancer - Nexavar (sorafenib) Significantly Extends Overall Survival By 44% In A	Angel	Medical News Today	0	05-06-2007 04:25 AM
Liver Cancer - Nexavar (sorafenib) Significantly Extends Overall Survival By 44% In A	Angel	Medical News Today	0	05-06-2007 01:26 AM
Nexavar Shown To Significantly Extend Survival For Patients With Advanced Liver Cance	Angel	Medical News Today	0	13-02-2007 12:40 AM

Remove advertisements

Hosted and Maintained by: